ERCP Clinical Trial
Official title:
Validation of Clinical Use of Additioned Endoscopy in Endoscopic Retrograde Cholangiopancreatography
Validation of clinical use of additioned endoscopy in Endoscopic Retrograde Cholangiopancreatography(ERCP) treatment.
Status | Recruiting |
Enrollment | 40 |
Est. completion date | December 2019 |
Est. primary completion date | December 2019 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 80 Years |
Eligibility |
Inclusion Criteria: - People who are indicated to ERCP treatment. Exclusion Criteria: - People who are not suitable for ERCP treatment. |
Country | Name | City | State |
---|---|---|---|
China | Changhai Hospital, Second Military Medical University | Shanghai | Shanghai |
Lead Sponsor | Collaborator |
---|---|
Changhai Hospital |
China,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Duration of ERCP treatment | To test if additioned endoscopy will have impact on duration of ERCP treatment | Duration of operation in each patient, ie. from beginning to the end of ERCP operation in each patient | |
Secondary | complications of ERCP treatment | To test if additioned endoscopy will have impact on incidence of ERCP complications, including perforation, bleeding, post-ERCP pancreatitis. | up to 1 month after ERCP completion |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02041390 -
Effect of Short Message Service Intervention on Stent Removal/Exchange Adherence in Patients With Benign Pancreaticobiliary Diseases
|
N/A | |
Completed |
NCT04619511 -
Risk Factors for Post-ESWL and Post-ERCP Pancreatitis
|
||
Terminated |
NCT00419549 -
Efficacy Study of Glyceryl-Trinitrate Patch and Parecoxib (Valdecoxib) for the Prevention of Pancreatitis After Endoscopic Retrograde Cholangiopancreatography (ERCP)
|
Phase 2/Phase 3 | |
Recruiting |
NCT04255095 -
Early Intervention of High Tension in the Pancreatic Duct on the Outcome of Severe Biliary Pancreatitis
|
N/A | |
Completed |
NCT05220774 -
Conscious Sedation Versus Anesthesia for ERCP
|
||
Completed |
NCT03698266 -
Is Needle Knife Fistulotomy An Effective First Step Strategy For All ERCPs?
|
N/A | |
Completed |
NCT04671095 -
Single Use ERCP Performance -SURE Study
|
||
Recruiting |
NCT05603702 -
STTEPP: Safety, Tolerability and Dose Limiting Toxicity of Lacosamide in Patients With Painful Chronic Pancreatitis
|
Phase 1 | |
Recruiting |
NCT04447976 -
Prospective Evaluation of Performance of Disposable Elevator Cap Duodenoscope During ERCP in Clinical Practice
|
||
Completed |
NCT03185390 -
Periampullary Lesions Via ERCP in Assuit University Hospital
|
N/A | |
Enrolling by invitation |
NCT03416205 -
A Prospective Study of Treating Duodenal Papillary Sphincter in Different Ways During ERCP
|
N/A | |
Recruiting |
NCT05211206 -
IV Fluids and Post-ERCP Pancreatitis
|
||
Not yet recruiting |
NCT04658212 -
A Multicenter Randomized Controlled Study of 3D Laparoscopy Versus Endoscopy in the Treatment of Choledocholithiasis
|
N/A | |
Recruiting |
NCT04661332 -
Registry of Endoscopic Retrograde Cholangiopancreatographies Performed in Humans
|
||
Terminated |
NCT02046590 -
RCT of Efficacy and Safety of Sedation Compared to General Anesthesia for ERCP
|
N/A | |
Recruiting |
NCT05219123 -
Guidewire Management in ERCP
|
||
Completed |
NCT00731198 -
Drotaverine Hydrochloride Versus Hyoscine-N-butylbromide for Duodenal Antimotility During Endoscopic Retrograde Cholangiopancreatography (ERCP)
|
Phase 3 | |
Completed |
NCT04167592 -
Benzydamine Hydrochloride Gargle in Reducing Propofol for ERCP
|
N/A | |
Completed |
NCT01873079 -
PPI for Prevention of Post-sphincterotomy Bleeding
|
Phase 3 | |
Not yet recruiting |
NCT05225909 -
aScope Single Use ERCP Study- ASSURE Study
|